I have often seen speculation that big money must treat big money well. You have to respect the $multi-m cash infusions.
My theory is that in September the investors of August got blind-sided by the EMEA delay. I can't believe they would be investing again without a very strong assurance.
"....on the biotech battle-field, you need some élan...."